Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSH.L Regulatory News (CSH)

  • There is currently no data for CSH

Form 8.3 - CSH LN

21 Jun 2023 15:30

RNS Number : 4678D
Syquant Capital
21 June 2023
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Identity of the person whose positions/dealings are being disclosed:

SYQUANT CAPITAL

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Civitas Social Housing plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

June 20, 2023

(f) Has the discloser previously disclosed, or are they today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

1p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Derivatives (other than options):

14,806,280

2.44%

 

(3) Options and agreements to purchase/sell:

 

 

 

 

TOTAL:

14,806,280

2.44%

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

 

 

 

 

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

 

CFD

 

increasing a long position

 

47,280

 

79.5 GBp

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

N/A

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

June 21, 2023

Contact name:

Laurent Boscherel

Telephone number:

+33 1 42 56 56 27

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETNKDBBKBKDAAB
Date   Source Headline
13th Feb 20194:24 pmRNSHolding(s) in Company
31st Jan 20197:00 amRNSNet Asset Values, Investment and Market Update
25th Jan 20194:39 pmRNSBespoke Supportive Tenancies: Grading Under Review
18th Jan 20193:01 pmRNSDirector/PDMR Shareholding
18th Jan 20192:59 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
17th Jan 20195:56 pmRNSDirector/PDMR Shareholding
14th Jan 20193:51 pmRNSHolding(s) in Company
14th Jan 20193:48 pmRNSHolding(s) in Company
2nd Jan 20194:16 pmRNSTotal Voting Rights
24th Dec 201811:45 amRNSHolding(s) in Company
21st Dec 20187:00 amRNSAcquisition
20th Dec 20185:45 pmRNSCivitas Social Housing
20th Dec 20185:29 pmRNSDirector/PDMR Shareholding
20th Dec 20181:28 pmRNSCONVERSION OF C SHARES
5th Dec 20187:00 amRNSUpdate on Westmoreland and the Company's Portfolio
5th Dec 20187:00 amRNSAcquisition
30th Nov 201810:07 amRNSAdviser's Update
29th Nov 20187:00 amRNSDividend Declaration
29th Nov 20187:00 amRNSHalf-year Report
15th Nov 20187:00 amRNSConversion of C Shares
9th Nov 20187:00 amRNSFTSE 250 Index Inclusion
8th Nov 20186:12 pmRNSWoodford Patient Capital Trust
2nd Nov 20187:00 amRNSAcquisition
1st Nov 20187:00 amRNSNet Asset Values, Investment and Market Update
31st Oct 20187:00 amRNSAcquisition
22nd Oct 20187:00 amRNSAcquisition
4th Oct 20187:00 amRNSAcquisition
20th Sep 20185:11 pmRNSHolding(s) in Company
7th Sep 201810:00 amRNSEPRA Index Inclusion
7th Sep 20187:00 amRNSAcquisition
29th Aug 20189:57 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
29th Aug 20189:35 amEQSHardman & Co Research: Advanced Oncotherapy (AVO): Treatment planning system agreement
28th Aug 20187:00 amRNSAcquisition
24th Aug 201812:57 pmEQSHardman & Co Research: Civitas Social Housing (CSH): Housing security
22nd Aug 201811:22 amRNS£37.6m acquisition of regulated social housing
9th Aug 201811:48 amRNSHolding(s) in Company
6th Aug 20187:00 amRNSAcquisition
3rd Aug 20187:00 amRNSNet Asset Values, Investment and Market Update
2nd Aug 20186:05 pmRNSResult of AGM
3rd Jul 20187:00 amRNSNotice of AGM
14th Jun 20188:23 amRNS£5.4 million acquisition
13th Jun 201810:04 amRNSInitiation research from QuotedData
12th Jun 20187:00 amRNSAnnual Results
12th Jun 20187:00 amRNS£20m increase in 3-Year Revolving Loan Facility
12th Jun 20187:00 amRNSPublication of Independent Social Impact Report
11th Jun 20187:00 amRNSAcquisition
11th Jun 20187:00 amRNS£500 million Invested into Social Housing
1st Jun 20187:00 amRNSAcquisition
30th May 20189:13 amRNSNet Asset Values, Investment and Market Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.